Lv1
20 积分 2025-02-19 加入
Cancer Research Communications
1天前
已完结
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study
1天前
已完结
Current treatment and recent progress in gastric cancer
1天前
已完结
皖公网安备34019202002308
